Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
Showing 1,201–1,260 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
… patient had not yet been reassessed). The 2 patients receiving Jorveza monotherapy are awaiting reassessment. 13/17 (76%) patients who…
…icipate in anti-platelet research with a majority in support of clopidogrel genotyping within a trial. Acknowledging patient preferences fo…
…nhibitors No – foundational therapy for HF, cannot be withheld. Spironolactone No – foundational therapy for HF, cannot be withheld. Methods T…
… long-term dual antithrombotic therapy (low-dose rivaroxaban or ticagrelor). This study compared cardiovascular outcomes of patients seen …
…h concern and a leading risk factor for cardiovascular disease. Zilebesiran, an investigational RNA interference therapeutic, aims to reduc…
…mmal Gi-coupled pathways, decreasing cAMP levels.In conclusion, fumarate selectively accumulates under hypoxia, acting both intracellula…
…topsy and showed positive drug results during autopsy, covering heroin, methamphetamine, ketamine, ecstasy and new psychoactive substa…
…high interest in long-acting injectable antiretroviral therapy (LAI-ART) among people with HIV (PWH), with many conveniences for uptake…
… experienced progressive disease on prior anti-PD-(L)1 therapy. Cavrotolimod, in combination with anti-PD-1 therapy, produced objective resp…
…entias (non-VaDs) (AHR 0.75; 95% CI 0.70 to 0.81) compared with metformin. No significant difference was observed for VaD. Subgroup analy…
… group (p=0.02); Filter+BCAS (p<0.001); and DEP+BCAS (p=0.001). EGCG treatment suppressed these effects.Conclusion EGCG therapy show…
…a greater than 5.0 percentage-point improvement. Alternatively, Onyx would need its cost reduced by approximately 57% (from $10,630 …